Approaches to the rational design of selective melanocortin receptor antagonists.
BACKGROUND
When establishing the physiological roles of specific receptors in normal and disease states, it is critical to have selective antagonist ligands for each receptor in a receptor system with several subtypes. The melanocortin receptors have five subtypes referred to as the melanocortin 1 receptor, melanocortin 2 receptor, melanocortin 3 receptor, melanocortin 4 receptor and melanocortin 5 receptor, and they are of critical importance for many aspects of human health and disease.


METHODS
This article reviews the current efforts to design selective antagonistic ligands for the five human melanocortin receptors summarizing the currently published orthosteric and allosteric antagonists for each of these receptors.


CONCLUSIONS
Though there has been progress, there are still few drugs available that address the many significant biological activities and diseases that are associated with these receptors, which is possibly due to the lack of receptor selectivity that these designed ligands are currently showing. The authors believe that further studies into the antagonists' 3D conformational and topographical properties in addition to future mutagenesis studies will provide greater insight into these ligands which could play a role in the treatment of various diseases in the future.
University of Arizona, Department of Chemistry and Biochemistry ,  1306 E. University Blvd., Tucson, AZ 85721 ,  USA   hruby@u.arizona.edu.
Victor J
VJ
Hruby
Minying
M
Cai
Joel
J
Nyberg
Dhanasekaran
D
Muthu